Index S&P 500
P/E 53.39
EPS (ttm) 7.41
Insider Own 6.46%
Shs Outstand 382.10M
Perf Week 4.34%
Market Cap 151.20B
Forward P/E 26.65
EPS next Y 14.85
Insider Trans -1.61%
Shs Float 357.49M
Perf Month 3.47%
Enterprise Value 166.14B
PEG 4.90
EPS next Q 3.07
Inst Own 80.49%
Short Float 1.43%
Perf Quarter 8.54%
Income 2.86B
P/S 6.51
EPS this Y 9.54%
Inst Trans 1.73%
Short Ratio 3.35
Perf Half Y 6.70%
Sales 23.22B
P/B 7.22
EPS next Y 11.19%
ROA 6.69%
Short Interest 5.11M
Perf YTD 9.88%
Book/sh 54.78
P/C 62.76
EPS next 5Y 10.89%
ROE 14.26%
52W High 406.19 -2.60%
Perf Year 16.19%
Cash/sh 6.30
P/FCF 42.27
EPS past 3/5Y 14.17% 7.20%
ROIC 8.00%
52W Low 314.93 25.62%
Perf 3Y 97.76%
Dividend Est. 3.21 (0.81%)
EV/EBITDA 26.73
Sales past 3/5Y 9.72% 8.71%
Gross Margin 61.73%
Volatility 1.93% 1.48%
Perf 5Y 111.79%
Dividend TTM 3.32 (0.84%)
EV/Sales 7.16
EPS Y/Y TTM -15.22%
Oper. Margin 22.19%
ATR (14) 6.47
Perf 10Y 306.19%
Dividend Ex-Date Jun 30, 2025
Quick Ratio 1.00
Sales Y/Y TTM 10.76%
Profit Margin 12.31%
RSI (14) 66.66
Recom 1.76
Dividend Gr. 3/5Y 7.89% 8.75%
Current Ratio 1.64
EPS Q/Q -17.28%
SMA20 3.37%
Beta 0.92
Target Price 431.58
Payout 41.74%
Debt/Eq 0.83
Sales Q/Q 11.88%
SMA50 4.45%
Rel Volume 0.74
Prev Close 393.55
Employees 53000
LT Debt/Eq 0.71
Earnings May 01 AMC
SMA200 5.72%
Avg Volume 1.53M
Price 395.63
IPO Mar 17, 1980
Option/Short Yes / Yes
EPS/Sales Surpr. 4.63% 3.07%
Trades
Volume 1,133,799
Change 0.53%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-25 Resumed
Citigroup
Buy
$450
Dec-02-24 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$370 → $445
Sep-10-24 Initiated
Wolfe Research
Outperform
$405
May-30-24 Initiated
Goldman
Neutral
$372
May-22-24 Upgrade
Needham
Hold → Buy
$392
Jan-31-24 Upgrade
Canaccord Genuity
Hold → Buy
$315 → $360
Oct-20-23 Initiated
ROTH MKM
Buy
$345
Sep-05-23 Upgrade
BofA Securities
Neutral → Buy
$310 → $315
Mar-29-23 Initiated
UBS
Neutral
$287
Jan-25-23 Initiated
KeyBanc Capital Markets
Sector Weight
Jan-09-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$240 → $284
Nov-01-22 Downgrade
Canaccord Genuity
Buy → Hold
$225 → $220
Oct-18-22 Initiated
Barclays
Overweight
$239
Oct-12-22 Initiated
Jefferies
Buy
$270
Jul-28-22 Upgrade
Edward Jones
Hold → Buy
Jul-21-22 Downgrade
Deutsche Bank
Buy → Hold
$285 → $205
Jul-11-22 Downgrade
BofA Securities
Buy → Neutral
$215
Apr-13-22 Initiated
Truist
Hold
$296
Mar-16-22 Upgrade
Bernstein
Mkt Perform → Outperform
$288 → $295
Mar-15-22 Resumed
Evercore ISI
Outperform
$284
Show Previous Ratings
Today 08:30AM
Jun-27-25 05:32AM
Jun-26-25 09:40AM
05:12AM
Jun-25-25 08:15AM
08:13AM
Loading…
08:13AM
01:30AM
Jun-24-25 08:27AM
Jun-18-25 07:34AM
Jun-16-25 12:04AM
Jun-13-25 08:19AM
Jun-11-25 05:00AM
Jun-06-25 06:02AM
Jun-05-25 01:59PM
09:37AM
11:30AM
Loading…
Jun-04-25 11:30AM
May-30-25 11:40AM
May-27-25 05:57PM
May-22-25 11:58AM
May-20-25 09:22AM
May-19-25 01:01PM
May-16-25 06:39AM
May-14-25 05:42AM
May-10-25 04:10AM
May-09-25 07:47AM
May-08-25 08:00AM
May-07-25 04:55AM
May-05-25 12:40AM
May-02-25 06:30PM
01:22PM
08:14AM
Loading…
08:14AM
(Thomson Reuters StreetEvents)
07:18AM
03:19AM
03:16AM
May-01-25 08:28PM
05:20PM
04:20PM
(Associated Press Finance)
04:05PM
08:00AM
(Investor's Business Daily)
Apr-30-25 11:27PM
10:54AM
09:01AM
Apr-29-25 11:40AM
09:11AM
08:00AM
Apr-28-25 09:15AM
Apr-27-25 02:55PM
02:22PM
Apr-26-25 01:53AM
Apr-24-25 10:02AM
Apr-21-25 03:21PM
Apr-17-25 08:10AM
Apr-15-25 12:21PM
06:46AM
Apr-14-25 05:15PM
Apr-10-25 11:40AM
Apr-09-25 12:19PM
06:27AM
05:05AM
Apr-07-25 10:08AM
08:00AM
Apr-03-25 02:24PM
10:29AM
Apr-01-25 04:26PM
04:05PM
Mar-31-25 03:03PM
(Investor's Business Daily)
11:28AM
04:39AM
Mar-29-25 04:05PM
Mar-26-25 08:29PM
10:15AM
Mar-25-25 04:15PM
Mar-22-25 12:31AM
Mar-20-25 09:40AM
09:05AM
08:23AM
Mar-19-25 11:03AM
Mar-17-25 07:01AM
Mar-12-25 09:00AM
Mar-11-25 03:59PM
08:03AM
Mar-10-25 12:08PM
Mar-06-25 01:36PM
Mar-05-25 09:45AM
Mar-04-25 08:07AM
Mar-03-25 08:07AM
Mar-01-25 06:14PM
Feb-28-25 04:04AM
Feb-26-25 11:18AM
Feb-25-25 06:38AM
Feb-24-25 05:23AM
Feb-20-25 04:49AM
Feb-19-25 08:30AM
Feb-17-25 11:21AM
03:07AM
Feb-16-25 07:07PM
Feb-13-25 05:54PM
08:00AM
Feb-12-25 09:14AM
06:55AM
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Berry William E Jr VP, Chief Accounting Officer May 12 '25 Sale 388.56 1,241 482,202 2,833 May 14 04:05 PM William Berry Jr Officer May 12 '25 Proposed Sale 388.56 1,241 482,197 May 12 04:18 PM Allan Golston Director May 12 '25 Proposed Sale 390.06 6,101 2,379,738 May 12 11:10 AM Allan Golston Director May 09 '25 Proposed Sale 383.67 4,184 1,605,264 May 09 11:49 AM STRYKER RONDA E Director May 06 '25 Sale 376.96 200,000 75,391,848 3,417,326 May 08 04:58 PM Glenn Boehnlein Officer May 07 '25 Proposed Sale 383.09 9,000 3,447,803 May 07 04:03 PM Stiles Spencer S Group President Mar 21 '25 Option Exercise 0.00 314 0 68,603 Mar 25 04:45 PM Pierce James Andrew Group President Mar 21 '25 Option Exercise 0.00 314 0 72,561 Mar 25 04:41 PM Menon Viju Group President Mar 21 '25 Option Exercise 0.00 187 0 16,934 Mar 25 04:37 PM Lobo Kevin Chair and CEO Mar 21 '25 Option Exercise 0.00 1,085 0 145,625 Mar 25 04:32 PM Fletcher Robert S VP, Chief Legal Officer Mar 21 '25 Option Exercise 0.00 144 0 15,261 Mar 25 04:28 PM Fink M Kathryn VP, Chief HR Officer Mar 21 '25 Option Exercise 0.00 102 0 14,157 Mar 25 04:24 PM Boehnlein Glenn S VP, Chief Financial Officer Mar 21 '25 Option Exercise 0.00 314 0 18,358 Mar 25 04:20 PM Becker Yin C VP, Chief Corp Affairs Officer Mar 21 '25 Option Exercise 0.00 42 0 34,586 Mar 25 04:11 PM Becker Yin C VP, Chief Corp Affairs Officer Feb 27 '25 Option Exercise 96.64 4,980 481,267 35,729 Feb 27 06:15 PM Golston Allan C. Director Feb 18 '25 Option Exercise 122.51 3,605 441,649 18,500 Feb 19 08:46 PM Golston Allan C. Director Feb 18 '25 Sale 383.07 2,458 941,586 14,895 Feb 19 08:46 PM Allan Golston Director Feb 18 '25 Proposed Sale 382.83 2,458 941,000 Feb 18 03:15 PM Silvernail Andrew K Director Feb 03 '25 Option Exercise 93.06 3,795 353,163 14,705 Feb 04 04:27 PM STRYKER RONDA E Director Jan 30 '25 Option Exercise 93.06 3,795 353,163 7,735 Feb 03 04:44 PM STRYKER RONDA E Director Jan 31 '25 Sale 392.24 201,392 78,993,068 3,642,075 Feb 03 04:44 PM STRYKER RONDA E Director Jan 31 '25 Proposed Sale 389.92 236,000 92,020,000 Feb 03 08:58 AM Stiles Spencer S Group President Jan 29 '25 Option Exercise 93.06 10,210 950,143 60,821 Jan 30 04:45 PM Pierce James Andrew Group President Jan 29 '25 Option Exercise 93.06 9,455 879,882 64,868 Jan 30 04:38 PM Boehnlein Glenn S VP, Chief Financial Officer Dec 31 '24 Option Exercise 122.51 300 36,753 5,331 Jan 02 04:44 PM Boehnlein Glenn S VP, Chief Financial Officer Dec 27 '24 Option Exercise 122.51 2,000 245,020 6,373 Dec 30 04:19 PM Boehnlein Glenn S VP, Chief Financial Officer Nov 18 '24 Option Exercise 122.51 4,500 551,295 7,352 Nov 19 04:36 PM Stiles Spencer S Group President Nov 15 '24 Sale 391.16 514 201,056 50,611 Nov 18 04:58 PM Stiles Spencer S Officer Nov 15 '24 Proposed Sale 389.88 514 200,398 Nov 15 11:39 AM Lobo Kevin Chair and CEO Nov 07 '24 Option Exercise 93.06 156,890 14,600,183 256,917 Nov 08 04:20 PM Lobo Kevin Chair and CEO Nov 07 '24 Sale 368.70 57,313 21,131,479 100,027 Nov 08 04:20 PM Kevin Lobo Officer Nov 07 '24 Proposed Sale 368.15 57,313 21,100,000 Nov 07 04:43 PM STRYKER RONDA E Director Nov 05 '24 Sale 367.37 230,000 84,494,990 3,086,608 Nov 07 04:33 PM Becker Yin C VP, Chief Corp Affairs Officer Nov 05 '24 Option Exercise 96.64 4,980 481,267 33,938 Nov 05 06:13 PM STRYKER RONDA E Director Nov 05 '24 Proposed Sale 365.00 230,000 83,950,000 Nov 05 10:10 AM Fink M Kathryn VP, Chief HR Officer Sep 16 '24 Option Exercise 122.51 7,347 900,081 17,389 Sep 17 06:01 PM Fink M Kathryn VP, Chief HR Officer Sep 17 '24 Sale 366.98 7,347 2,696,186 10,042 Sep 17 06:01 PM Fink M Kathryn VP, Chief HR Officer Sep 13 '24 Sale 370.00 2,121 784,770 10,042 Sep 17 06:01 PM Fink M Kathryn Officer Sep 17 '24 Proposed Sale 371.19 7,347 2,727,133 Sep 17 04:07 PM Fink M Kathryn Officer Sep 13 '24 Proposed Sale 370.00 2,121 784,770 Sep 13 04:06 PM Menon Viju Group President Aug 27 '24 Sale 355.00 600 213,000 9,069 Aug 27 05:22 PM Viju Menon Officer Aug 27 '24 Proposed Sale 355.00 600 213,000 Aug 27 04:04 PM STRYKER RONDA E Director Aug 06 '24 Sale 323.46 190,000 61,457,149 3,316,608 Aug 08 04:23 PM STRYKER RONDA E Director Aug 06 '24 Proposed Sale 322.45 190,000 61,265,500 Aug 06 10:57 AM Boehnlein Glenn S VP, Chief Financial Officer Aug 02 '24 Sale 333.00 20,000 6,660,000 2,852 Aug 02 04:17 PM Glenn Boehnlein Officer Aug 02 '24 Proposed Sale 333.00 20,000 6,659,994 Aug 02 11:43 AM Boehnlein Glenn S VP, Chief Financial Officer Jul 02 '24 Option Exercise 122.51 25,000 3,062,750 40,012 Jul 03 04:33 PM